Table of Contents Chapter 1 Overview of Urinary Tract Infection Therapeutics 1.1 Definition of Urinary Tract Infection Therapeutics in This Report 1.2 Commercial Types of Urinary Tract Infection Therapeutics 1.2.1 Quinolones 1.2.2 Penicillin & Combinations 1.2.3 Cephalosporin 1.2.4 Tetracycline 1.2.5 Sulphonamides 1.2.6 Nitrofurans 1.2.7 Other 1.3 Downstream Application of Urinary Tract Infection Therapeutics 1.3.1 Hospital Pharmacies 1.3.2 Retail Pharmacies 1.3.3 E-Commerce 1.4 Development History of Urinary Tract Infection Therapeutics 1.5 Market Status and Trend of Urinary Tract Infection Therapeutics 2013-2023 1.5.1 Global Urinary Tract Infection Therapeutics Market Status and Trend 2013-2023 1.5.2 Regional Urinary Tract Infection Therapeutics Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Urinary Tract Infection Therapeutics 2013-2017 2.2 Sales Market of Urinary Tract Infection Therapeutics by Regions 2.2.1 Sales Volume of Urinary Tract Infection Therapeutics by Regions 2.2.2 Sales Value of Urinary Tract Infection Therapeutics by Regions 2.3 Production Market of Urinary Tract Infection Therapeutics by Regions 2.4 Global Market Forecast of Urinary Tract Infection Therapeutics 2018-2023 2.4.1 Global Market Forecast of Urinary Tract Infection Therapeutics 2018-2023 2.4.2 Market Forecast of Urinary Tract Infection Therapeutics by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Urinary Tract Infection Therapeutics by Types 3.2 Sales Value of Urinary Tract Infection Therapeutics by Types 3.3 Market Forecast of Urinary Tract Infection Therapeutics by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Urinary Tract Infection Therapeutics by Downstream Industry 4.2 Global Market Forecast of Urinary Tract Infection Therapeutics by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Urinary Tract Infection Therapeutics Market Status by Countries 5.1.1 North America Urinary Tract Infection Therapeutics Sales by Countries (2013-2017) 5.1.2 North America Urinary Tract Infection Therapeutics Revenue by Countries (2013-2017) 5.1.3 United States Urinary Tract Infection Therapeutics Market Status (2013-2017) 5.1.4 Canada Urinary Tract Infection Therapeutics Market Status (2013-2017) 5.1.5 Mexico Urinary Tract Infection Therapeutics Market Status (2013-2017) 5.2 North America Urinary Tract Infection Therapeutics Market Status by Manufacturers 5.3 North America Urinary Tract Infection Therapeutics Market Status by Type (2013-2017) 5.3.1 North America Urinary Tract Infection Therapeutics Sales by Type (2013-2017) 5.3.2 North America Urinary Tract Infection Therapeutics Revenue by Type (2013-2017) 5.4 North America Urinary Tract Infection Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Urinary Tract Infection Therapeutics Market Status by Countries 6.1.1 Europe Urinary Tract Infection Therapeutics Sales by Countries (2013-2017) 6.1.2 Europe Urinary Tract Infection Therapeutics Revenue by Countries (2013-2017) 6.1.3 Germany Urinary Tract Infection Therapeutics Market Status (2013-2017) 6.1.4 UK Urinary Tract Infection Therapeutics Market Status (2013-2017) 6.1.5 France Urinary Tract Infection Therapeutics Market Status (2013-2017) 6.1.6 Italy Urinary Tract Infection Therapeutics Market Status (2013-2017) 6.1.7 Russia Urinary Tract Infection Therapeutics Market Status (2013-2017) 6.1.8 Spain Urinary Tract Infection Therapeutics Market Status (2013-2017) 6.1.9 Benelux Urinary Tract Infection Therapeutics Market Status (2013-2017) 6.2 Europe Urinary Tract Infection Therapeutics Market Status by Manufacturers 6.3 Europe Urinary Tract Infection Therapeutics Market Status by Type (2013-2017) 6.3.1 Europe Urinary Tract Infection Therapeutics Sales by Type (2013-2017) 6.3.2 Europe Urinary Tract Infection Therapeutics Revenue by Type (2013-2017) 6.4 Europe Urinary Tract Infection Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Urinary Tract Infection Therapeutics Market Status by Countries 7.1.1 Asia Pacific Urinary Tract Infection Therapeutics Sales by Countries (2013-2017) 7.1.2 Asia Pacific Urinary Tract Infection Therapeutics Revenue by Countries (2013-2017) 7.1.3 China Urinary Tract Infection Therapeutics Market Status (2013-2017) 7.1.4 Japan Urinary Tract Infection Therapeutics Market Status (2013-2017) 7.1.5 India Urinary Tract Infection Therapeutics Market Status (2013-2017) 7.1.6 Southeast Asia Urinary Tract Infection Therapeutics Market Status (2013-2017) 7.1.7 Australia Urinary Tract Infection Therapeutics Market Status (2013-2017) 7.2 Asia Pacific Urinary Tract Infection Therapeutics Market Status by Manufacturers 7.3 Asia Pacific Urinary Tract Infection Therapeutics Market Status by Type (2013-2017) 7.3.1 Asia Pacific Urinary Tract Infection Therapeutics Sales by Type (2013-2017) 7.3.2 Asia Pacific Urinary Tract Infection Therapeutics Revenue by Type (2013-2017) 7.4 Asia Pacific Urinary Tract Infection Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Urinary Tract Infection Therapeutics Market Status by Countries 8.1.1 Latin America Urinary Tract Infection Therapeutics Sales by Countries (2013-2017) 8.1.2 Latin America Urinary Tract Infection Therapeutics Revenue by Countries (2013-2017) 8.1.3 Brazil Urinary Tract Infection Therapeutics Market Status (2013-2017) 8.1.4 Argentina Urinary Tract Infection Therapeutics Market Status (2013-2017) 8.1.5 Colombia Urinary Tract Infection Therapeutics Market Status (2013-2017) 8.2 Latin America Urinary Tract Infection Therapeutics Market Status by Manufacturers 8.3 Latin America Urinary Tract Infection Therapeutics Market Status by Type (2013-2017) 8.3.1 Latin America Urinary Tract Infection Therapeutics Sales by Type (2013-2017) 8.3.2 Latin America Urinary Tract Infection Therapeutics Revenue by Type (2013-2017) 8.4 Latin America Urinary Tract Infection Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Urinary Tract Infection Therapeutics Market Status by Countries 9.1.1 Middle East and Africa Urinary Tract Infection Therapeutics Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Urinary Tract Infection Therapeutics Revenue by Countries (2013-2017) 9.1.3 Middle East Urinary Tract Infection Therapeutics Market Status (2013-2017) 9.1.4 Africa Urinary Tract Infection Therapeutics Market Status (2013-2017) 9.2 Middle East and Africa Urinary Tract Infection Therapeutics Market Status by Manufacturers 9.3 Middle East and Africa Urinary Tract Infection Therapeutics Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Urinary Tract Infection Therapeutics Sales by Type (2013-2017) 9.3.2 Middle East and Africa Urinary Tract Infection Therapeutics Revenue by Type (2013-2017) 9.4 Middle East and Africa Urinary Tract Infection Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Urinary Tract Infection Therapeutics 10.1 Global Economy Situation and Trend Overview 10.2 Urinary Tract Infection Therapeutics Downstream Industry Situation and Trend Overview Chapter 11 Urinary Tract Infection Therapeutics Market Competition Status by Major Manufacturers 11.1 Production Volume of Urinary Tract Infection Therapeutics by Major Manufacturers 11.2 Production Value of Urinary Tract Infection Therapeutics by Major Manufacturers 11.3 Basic Information of Urinary Tract Infection Therapeutics by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Urinary Tract Infection Therapeutics Major Manufacturer 11.3.2 Employees and Revenue Level of Urinary Tract Infection Therapeutics Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Urinary Tract Infection Therapeutics Major Manufacturers Introduction and Market Data 12.1 Pfizer 12.1.1 Company profile 12.1.2 Representative Urinary Tract Infection Therapeutics Product 12.1.3 Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Pfizer 12.2 AstraZeneca 12.2.1 Company profile 12.2.2 Representative Urinary Tract Infection Therapeutics Product 12.2.3 Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of AstraZeneca 12.3 Novartis International 12.3.1 Company profile 12.3.2 Representative Urinary Tract Infection Therapeutics Product 12.3.3 Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Novartis International 12.4 Johnson & Johnson 12.4.1 Company profile 12.4.2 Representative Urinary Tract Infection Therapeutics Product 12.4.3 Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Johnson & Johnson 12.5 F. Hoffmann La Roche 12.5.1 Company profile 12.5.2 Representative Urinary Tract Infection Therapeutics Product 12.5.3 Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of F. Hoffmann La Roche 12.6 Teva Pharmaceutical Industries 12.6.1 Company profile 12.6.2 Representative Urinary Tract Infection Therapeutics Product 12.6.3 Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries 12.7 Boehringer Ingelheim 12.7.1 Company profile 12.7.2 Representative Urinary Tract Infection Therapeutics Product 12.7.3 Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim 12.8 Cipla 12.8.1 Company profile 12.8.2 Representative Urinary Tract Infection Therapeutics Product 12.8.3 Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Cipla Chapter 13 Upstream and Downstream Market Analysis of Urinary Tract Infection Therapeutics 13.1 Industry Chain of Urinary Tract Infection Therapeutics 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Urinary Tract Infection Therapeutics 14.1 Cost Structure Analysis of Urinary Tract Infection Therapeutics 14.2 Raw Materials Cost Analysis of Urinary Tract Infection Therapeutics 14.3 Labor Cost Analysis of Urinary Tract Infection Therapeutics 14.4 Manufacturing Expenses Analysis of Urinary Tract Infection Therapeutics Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Quinolones Table Advantage and Disadvantage of Penicillin & Combinations Table Advantage and Disadvantage of Cephalosporin Table Advantage and Disadvantage of Tetracycline Table Advantage and Disadvantage of Sulphonamides Table Advantage and Disadvantage of Nitrofurans Table Advantage and Disadvantage of Other Table Sales Volume of Urinary Tract Infection Therapeutics by Regions 2013-2017 Table Sales Value of Urinary Tract Infection Therapeutics by Regions 2013-2017 Table Production Volume of Urinary Tract Infection Therapeutics by Regions 2013-2017 Table Global Sales Volume of Urinary Tract Infection Therapeutics by Regions 2018-2023 Table Global Sales Value of Urinary Tract Infection Therapeutics by Regions 2018-2023 Table Global Production Volume of Urinary Tract Infection Therapeutics by Regions 2018-2023 Table Sales Volume of Urinary Tract Infection Therapeutics by Types 2013-2017 Table Sales Value of Urinary Tract Infection Therapeutics by Types 2013-2017 Table Sales Volume Forecast of Urinary Tract Infection Therapeutics by Types 2018-2023 Table Sales Value Forecast of Urinary Tract Infection Therapeutics by Types 2018-2023 Table Sales Volume of Urinary Tract Infection Therapeutics by Downstream Industry 2013-2017 Table Sales Volume Forecast of Urinary Tract Infection Therapeutics by Downstream Industry 2018-2023 Table North America Urinary Tract Infection Therapeutics Sales by Countries (2013-2017) Table North America Urinary Tract Infection Therapeutics Sales Share by Countries (2013-2017) Table North America Urinary Tract Infection Therapeutics Revenue by Countries (2013-2017) Table North America Urinary Tract Infection Therapeutics Revenue Market Share by Countries (2013-2017) Table North America Urinary Tract Infection Therapeutics Sales by Type (2013-2017) Table North America Urinary Tract Infection Therapeutics Sales Share by Type (2013-2017) Table North America Urinary Tract Infection Therapeutics Revenue by Type (2013-2017) Table North America Urinary Tract Infection Therapeutics Revenue Share by Type (2013-2017) Table North America Urinary Tract Infection Therapeutics Sales by Downstream Industry (2013-2017) Table North America Urinary Tract Infection Therapeutics Sales Share by Downstream Industry (2013-2017) Table Europe Urinary Tract Infection Therapeutics Sales by Countries (2013-2017) Table Europe Urinary Tract Infection Therapeutics Sales Share by Countries (2013-2017) Table Europe Urinary Tract Infection Therapeutics Revenue by Countries (2013-2017) Table Europe Urinary Tract Infection Therapeutics Revenue Market Share by Countries (2013-2017) Table Europe Urinary Tract Infection Therapeutics Sales by Type (2013-2017) Table Europe Urinary Tract Infection Therapeutics Sales Share by Type (2013-2017) Table Europe Urinary Tract Infection Therapeutics Revenue by Type (2013-2017) Table Europe Urinary Tract Infection Therapeutics Revenue Share by Type (2013-2017) Table Europe Urinary Tract Infection Therapeutics Sales by Downstream Industry (2013-2017) Table Europe Urinary Tract Infection Therapeutics Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Urinary Tract Infection Therapeutics Sales by Countries (2013-2017) Table Asia Pacific Urinary Tract Infection Therapeutics Sales Share by Countries (2013-2017) Table Asia Pacific Urinary Tract Infection Therapeutics Revenue by Countries (2013-2017) Table Asia Pacific Urinary Tract Infection Therapeutics Revenue Market Share by Countries (2013-2017) Table Asia Pacific Urinary Tract Infection Therapeutics Sales by Type (2013-2017) Table Asia Pacific Urinary Tract Infection Therapeutics Sales Share by Type (2013-2017) Table Asia Pacific Urinary Tract Infection Therapeutics Revenue by Type (2013-2017) Table Asia Pacific Urinary Tract Infection Therapeutics Revenue Share by Type (2013-2017) Table Asia Pacific Urinary Tract Infection Therapeutics Sales by Downstream Industry (2013-2017) Table Asia Pacific Urinary Tract Infection Therapeutics Sales Share by Downstream Industry (2013-2017) Table Latin America Urinary Tract Infection Therapeutics Sales by Countries (2013-2017) Table Latin America Urinary Tract Infection Therapeutics Sales Share by Countries (2013-2017) Table Latin America Urinary Tract Infection Therapeutics Revenue by Countries (2013-2017) Table Latin America Urinary Tract Infection Therapeutics Revenue Market Share by Countries (2013-2017) Table Latin America Urinary Tract Infection Therapeutics Sales by Type (2013-2017) Table Latin America Urinary Tract Infection Therapeutics Sales Share by Type (2013-2017) Table Latin America Urinary Tract Infection Therapeutics Revenue by Type (2013-2017) Table Latin America Urinary Tract Infection Therapeutics Revenue Share by Type (2013-2017) Table Latin America Urinary Tract Infection Therapeutics Sales by Downstream Industry (2013-2017) Table Latin America Urinary Tract Infection Therapeutics Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Urinary Tract Infection Therapeutics Sales by Regions (2013-2017) Table Middle East and Africa Urinary Tract Infection Therapeutics Sales Share by Regions (2013-2017) Table Middle East and Africa Urinary Tract Infection Therapeutics Revenue by Regions (2013-2017) Table Middle East and Africa Urinary Tract Infection Therapeutics Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Urinary Tract Infection Therapeutics Sales by Type (2013-2017) Table Middle East and Africa Urinary Tract Infection Therapeutics Sales Share by Type (2013-2017) Table Middle East and Africa Urinary Tract Infection Therapeutics Revenue by Type (2013-2017) Table Middle East and Africa Urinary Tract Infection Therapeutics Revenue Share by Type (2013-2017) Table Middle East and Africa Urinary Tract Infection Therapeutics Sales by Downstream Industry (2013-2017) Table Middle East and Africa Urinary Tract Infection Therapeutics Sales Share by Downstream Industry (2013-2017) Table Production Volume of Urinary Tract Infection Therapeutics by Major Manufacturers 2013-2017 Table Production Value of Urinary Tract Infection Therapeutics by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Urinary Tract Infection Therapeutics Major Manufacturer Table Employees and Revenue Level of Urinary Tract Infection Therapeutics Major Manufacturer Table Representative Urinary Tract Infection Therapeutics Product One of Pfizer Table Representative Urinary Tract Infection Therapeutics Product Two of Pfizer Table Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Pfizer 2013-2017 Table Representative Urinary Tract Infection Therapeutics Product One of AstraZeneca Table Representative Urinary Tract Infection Therapeutics Product Two of AstraZeneca Table Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of AstraZeneca 2013-2017 Table Representative Urinary Tract Infection Therapeutics Product One of Novartis International Table Representative Urinary Tract Infection Therapeutics Product Two of Novartis International Table Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Novartis International 2013-2017 Table Representative Urinary Tract Infection Therapeutics Product One of Johnson & Johnson Table Representative Urinary Tract Infection Therapeutics Product Two of Johnson & Johnson Table Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017 Table Representative Urinary Tract Infection Therapeutics Product One of F. Hoffmann La Roche Table Representative Urinary Tract Infection Therapeutics Product Two of F. Hoffmann La Roche Table Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of F. Hoffmann La Roche 2013-2017 Table Representative Urinary Tract Infection Therapeutics Product One of Teva Pharmaceutical Industries Table Representative Urinary Tract Infection Therapeutics Product Two of Teva Pharmaceutical Industries Table Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries 2013-2017 Table Representative Urinary Tract Infection Therapeutics Product One of Boehringer Ingelheim Table Representative Urinary Tract Infection Therapeutics Product Two of Boehringer Ingelheim Table Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim 2013-2017 Table Representative Urinary Tract Infection Therapeutics Product One of Cipla Table Representative Urinary Tract Infection Therapeutics Product Two of Cipla Table Urinary Tract Infection Therapeutics Sales, Revenue, Price and Gross Margin of Cipla 2013-2017